Livalo
NDC 66869-204, pitavastatin calcium, tablet, film coated, from Kowa Pharmaceuticals America, Inc..
- Product NDC
- 66869-204
- Status
- Listed
- Labeler
- Kowa Pharmaceuticals America, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022363
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66869-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PITAVASTATIN CALCIUM2.09 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66869-204-90 | 66869020490 | 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-204-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/44dcbf97-99ec-427c-ba50-207e0069d6d2NADAC price for package 66869020490
GET /v1/drugs/nadac/66869020490
Use it
Look up 66869-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66869-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66869-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.